With marijuana getting legal acceptance in Canada and 30 states and District of Columbia in the US, Marijuana and cannabis stocks have huge growth potential. Companies operating in both medical and recreational marijuana offer the most opportunities for investors. In California alone, consumers bought $339 million worth of marijuana products in the first two months after legalization. The state projects that cannabis sales for the next six months of the fiscal year would come in at $1.15 billion. Legal sales in North America for 2017 were at $9.2 billion. BDS Analytics projects that sales will grow at 27% rate through 2021 to $24 billion. In this article we will review 3 marijuana stocks Canopy Growth Corp (NYSE: CGC), Aurora Cannabis Inc (TSE: ACB) andCronos Group (NASDAQ: CRON) that need to be considered as a viable investment for a diversified portfolio.
Canopy Growth Corp (NYSE: CGC)
Canopy Growth Corp (NYSE: CGC) is one of the bigger names in the medical marijuana industry. Canopy Growth has increased its product line into marijuana-based oils and soft-gel capsules. Canopy Growth is increasing its harvesting rate rapidly. In the fourth quarter of 2017, the company’s marijuana harvest was up by 51.2% year over year. New York-based Constellation Brands has over a 10% ownership stake in Canopy Growth. Some analysts think that Canopy Growth Corp (NYSE: CGC) next step will be to expand into weed-based edible products, which have show to have mass acceptance as an alternative to smoking and vaping, consumable represent a huge growth market. According to an estimate, about 46% of Canadians would buy legal marijuana food products. Canopy Growth has also managed to put a cap on its production costs.
Aurora Cannabis Inc (TSE: ACB)
No list of best marijuana stocks is complete without Aurora Cannabis Inc (TSE: ACB), Vancouver-based Weed Company. Aurora Cannabis is making headlines as the company announced Tuesday it will get up to $250-million debt facility from the Bank of Montreal. The debt facility will be primarily secured by Aurora’s production facilities Aurora Mountain, Aurora Vie and Aurora sky. Another smart move by Aurora Cannabis they announce on June 20, that they will be spinning off its subsidiary unit Australis Capital Inc. to pursue cannabis related investments in the US. In May, Aurora Cannabis announced the acquisition of a rival MedReleaf Corp for a whopping $2.51 billion. With this move the company has entered into the medical cannabis industry. Aurora and MedReleaf together expect to produce over 570,000 kilograms per year of cannabis through nine facilities in Canada and two in Denmark.
Cronos Group (NASDAQ: CRON)
Cronos Group (NASDAQ: CRON) is one of the pioneer companies to get listed on the US stock exchange. The company has licenses and partnerships all over the world, including Spain, Germany, Denmark, and more. The company has a partnership with Pohl-Boskamp, which distributes to over 12,000 German pharmacies. This partnership gives Cronos a much-needed launching pad in Europe. The company is also building major facilities in Australia and Israel. It plans to increase its annual production capacity to 47,000 kilograms by 2019.
Author does not have investment in stock discussed in this article. Sign-up for our newsletter so you don’t miss any hot investment opportunities. Also download our recently published Best Blockchain Stock To Invest In Right Now or Volatility Survival Guide report absolutely free.